The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Critical Care Diagnostics sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Critical Care Diagnostics formerly Critical Care Diagnostics Inc, is a medical device company that manufactures and sells medical devices that are used in emergency and surgical situations. It provides medical products and services to healthcare professionals. The company’s products include hemostatix thermal scalpel for ultimate surgical precision, visualization, and control; STIC, an intra-compartmental pressure monitor system for continuous readings of compartment pressure and T/Pump advanced therapeutic warming and cooling system for temperature control. It offers products through sales associates situated nationwide. C2Dx is headquartered in Schoolcraft, Michigan, the US.
The key metrics of Critical Care Diagnostics related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Critical Care Diagnostics is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Critical Care Diagnostics.
For a detailed understanding of the performance of Critical Care Diagnostics, buy the report here.